Generic device company Merxin has announced the launch of its MRX003 dry powder inhaler, an off-the-shelf capsule based DPI intended for generic tiotropium 505j submissions.
According to an announcement by Merxin’s sister company Aedestra, the MRX003 DPI has the same design and features as the HandiHaler device, including the same air flow, same NGI profile, and audible feedback.
Merxin previously announced the launch of a generic blister DPI for combination products.
Read the Aedestra announcement.
